Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-24-084762

Chief Technology Officer sold 14,851 shares at $6.47 ($96,125)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2024-07-17 Sale −14,851 $6.47 $96,125 146,049 D
Open-market sales · 14,851 sh · avg $6.47 · $96,125
Loading xslF345X05/ownership.xml…